International projects and partnerships

Jointly managed by the European Bioinformatics Institute (EMBL-EBI) in Cambridge (UK) and the Centre for Genomic Regulation (CRG) in Barcelona, the EGA provides an invaluable service to the worldwide biomedical research community. The teams leading the EGA are involved in several international partnerships and consortia in numerous scientific fields, where they contribute to ambitious projects. In addition to the project listed below, The EGA is in a long-standing partnership with the Global Alliance for Genomics & Health (GA4GH), as described on the dedicated page.

  Project   Domain   Funder
CINECA (2019-2022) Consortium providing a Federated solution enabling population scale genomic and biomolecular data accessible across international borders accelerating research and improving the health of individuals resident across continents. Large-scale genomics and health data European commission - H2020 programme

EASI-Genomics (2019-2022). A project designed to provide easy access to cutting-edge DNA sequencing technologies to researchers from academia and industry, within a framework that ensures compliance with ethical and legal requirements, as well as FAIR and secure data management. Next generation sequencing European commission - H2020 programme

EJP-RD (2019-2023) An European consortium built to create a comprehensive, sustainable ecosystem allowing a virtuous circle between research, care and medical innovation. Rare diseases European commission - H2020 programme

ELIXIR BEACON IS (2019-2021). This study follows on from a number of earlier activities that have established the ELIXIR Beacon Project. The main aim is to extend the Beacon protocol, developed at EGA, to become the reference ELIXIR Data Discovery product. Discovery tool in bioinformatics ELIXIR

ELIXIR FHD IS (2019-2021). This project coordinates the delivery of FAIR compliant metadata standards, interfaces, and reference implementation to support the federated ELIXIR network of human data resources. Human genomic data ELIXIR

ELIXIR Rare Disease (2019-2021) The Rare Disease Community extends and generalises the system of access authorisation and high volume secure data transfer developed within the EGA. The goal of the Community is to create a federated infrastructure that will enable researchers to discover, access and analyse different rare disease repositories across Europe. It is doing this in partnership with other European infrastructure projects, namely RD-CONNECT, BBMRI-ERIC and E-Rare. Rare diseases ELIXIR

ELIXIR-CONVERGE (2020-2023) An alliance with the goal of Connecting and aligning ELIXIR Nodes to deliver sustainable FAIR life-science data management services. Data Management and Infectious diseases European commission - H2020 programme

EOSC-life (2019-2023) EOSC-Life brings together the 13 Life Science research infrastructures (LS RIs) to create an open, digital and collaborative space for biological and medical research. The project will publish ‘FAIR’ data and a catalogue of services provided by participating RIs for the management, storage and reuse of data in the European Open Science Cloud (EOSC). Not Applicable European commission - H2020 programme

EUCANCan (2019-2022) A federated network aiming at implementing a cultural, technological and legal integrated framework across Europe and Canada, to enable and facilitate the efficient sharing of cancer genomic data. Cancer European commission - H2020 programme

EuCanImage (2020-2024) A European Cancer Image Platform Linked to Biological and Health Data for Next-Generation Artificial Intelligence and Precision Medicine in Oncology. AI solutions in oncology European commission - H2020 programme

EuCanShare (2018-2022). An EU-Canada joint infrastructure for next-generation multi-Study Heart research.. Cardiovascular Diseases European commission - H2020 programme

GenoMed4ALL (2020-2024) A consortium built to empower personalized medicine in the field of haematological diseases through the use of AI and the pooling of genomic and clinical data. AI solutions in hematological diseases European commission - H2020 programme

HealthyCloud (2021-2023). This consortium will contribute a Strategic Agenda towards the European Health Research and Innovation Cloud. The project will work in collaboration with a broad range of stakeholders to ensure that all voices are included and that the results are technically and ethically sound. Not Applicable European commission - H2020 programme

IHCC (2020-2021) The International HundredK+ Cohorts Consortium aims to create a global platform for translational research – informing the biological and genetic basis for disease and improving clinical care and population health. Translational research NIH, The Wellcome Trust, CZI

LaMarató (2021-2023). It is a project aimed at creating and developing a catalan interhospitalary network to interrogate genetic variants from thousands of genetic tests carried out in patients with rare diseases from the main catalan hospitals. Genomic and health data Fundació la Marató de TV3 (catalan fundation)

PPCG (2019-2022) The Pan Prostate Cancer Group aims to harmonise and interrogate Whole Genome DNA Sequence data generated around the world from over 2000 men with prostate cancer, with associated transcriptome and methylome data to include men from different clinical categories, and ethnicities. This project is about providing breakthrough advances through analysis of a very large series of Whole Genome DNA data from prostate cancer contributed by many of the leading scientists and clinicians working in prostate cancer genomics. Cancer Cancer Research UK

Solve-RD (2018-2022). Solve-RD - solving the unsolved rare diseases - is a research project funded by the European Commission. It echoes the ambitious goals set out by the International Rare Diseases Research Consortium (IRDiRC) to deliver diagnostic tests for most rare diseases by 2020. The current diagnostic and subsequent therapeutic management of rare diseases is still highly unsatisfactory for a large proportion of rare disease patients - the unsolved RD cases. For these unsolved rare diseases, we are unable to explain the etiology responsible for the disease phenotype, predict the individual disease risk and/or rate of disease progression, and/or quantitate the risk of relatives to develop the same disorder. Rare Diseases European commission - H2020 programme

UK Biobank (2019-2023) UK Biobank is a large-scale biomedical database and research resource, containing in-depth genetic and health information from half a million UK participants. This project is to archive whole genome sequencing and other genetic data for UK Biobank participants. Large-scale genomics and health data The Wellcome Trust, UKRI, Amgen, AstraZeneca, GSK, Johnson & Johnson.

VEIS (2019-2021). The core mission of VEIS is to create an open ecosystem of technologies that will address and adapt to the requirements of the systems used to analyse and interpret -omics and clinical data in research and application environments in biomedicine. The aim of the project is to leverage the value of the EGA for both industry and society. Oncology and Rare Diseases Generalitat de Catalunya and European Regional Development Fund (ERDF)

Point to notice: Brief descriptions have been extracted from the respective project’s websites.